cipla - Latest News on cipla | Read Breaking News on Zee News

FIPB to take up 25 FDI proposals on Sept 22

Last Updated: Thursday, September 10, 2015, 16:03

FIPB will take up 25 foreign direct investment (FDI) proposals, including those of Aditya Birla Nuvo, Cipla, Sun Pharma Advanced Research and HDFC Capital Advisors, on September 22.

Cipla to buy two US generic drug firms for $550 million

Last Updated: Friday, September 4, 2015, 10:53

Cipla Ltd said on Friday it has agreed to buy two generics businesses in the United States in an all-cash deals worth $550 million, as part of an effort to boost its presence in the world`s largest generics market.

Cipla gains 3% on strong revenue outlook

Last Updated: Friday, August 28, 2015, 11:54

Shares of Cipla Friday soared nearly 3 percent in morning trade on bourses after the company said it expects 20 percent growth in revenues in the current fiscal.

Cipla shares end 5% lower on profit-booking

Last Updated: Monday, August 17, 2015, 22:58

Shares of drug major Cipla Monday pared early gains on profit-booking, falling 5 percent, even as the company reported an over two-fold jump in consolidated net profit for the quarter ended June 30, 2015.

Cipla Q1 net profit zooms over two-fold to Rs 651 crore

Last Updated: Friday, August 14, 2015, 19:48

Drug major Cipla on Friday reported an over two-fold jump in its consolidated net profit to Rs 650.61 crore for the quarter ended June 30, 2015 mainly on account of robust sales.

Cipla to pay $26 mn upfront for 51% stake in Ugandan firm

Last Updated: Friday, July 24, 2015, 23:37

Drug major Cipla has re-negotiated payment terms for acquiring majority stake in Uganda's Quality Chemicals and now decided to pay USD 26 million (around Rs 166 crore) upfront to the shareholders of the African firm.

FIL Capital to invest in Cipla's consumer healthcare biz

Last Updated: Tuesday, July 21, 2015, 11:19

Drug major Cipla on Tuesday said its board has approved a potential investment by FIL Capital Investments (Mauritius) II Ltd in its consumer healthcare business.

Cipla elevates Samina Vaziralli to its board

Last Updated: Thursday, July 9, 2015, 22:08

Drug major Cipla Thursday announced the appointment of Samina Vaziralli as executive director on its board, paving way for a bigger role for her, nearly two weeks after another heir apparent Kamil Hamied quiting the pharma company.

Cipla heir apparent Kamil Hamied quits, bigger role for sister Samina

Last Updated: Wednesday, June 24, 2015, 18:31

Pharmaceuticals major Cipla Chairman Yusuf K Hamied's nephew Kamil Hamied, who has been understood to be groomed to take over the reins of the drug maker, has quit and his sister Samina Vaziralli has assumed an expanded role in the company.

Cipla gets USFDA nod for Lopinavir, Ritonavir oral pellets

Last Updated: Wednesday, June 3, 2015, 17:06

The company stock closed at Rs 634.90, down 0.95 per cent, on the BSE.

Lupin, Cipla bid for UCB's US generic drugs portfolio: Report

Last Updated: Monday, June 1, 2015, 18:56

Generic drugmakers Lupin Ltd and Cipla Ltdare among the companies bidding for top Belgian drugmaker UCB SA`s U.S. generic drugs business, a leading dailey reported on Monday, citing unnamed people with knowledge of the matter.

Stempeutics' Stempeucel gets Orphan Drug status in Europe

Last Updated: Monday, June 1, 2015, 14:31

Shares of Cipla were trading at Rs 669.05 per scrip in the afternoon trade on BSE, up 2.86 percent from its previous close.